BOULDER, Colo., June 5 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the Needham Annual Biotechnology and Medical
Technology Conference on June 14 in New York City. The public is welcome to
participate in the conference through an audio webcast on the Array
BioPharma website.
Event: Needham Annual Biotechnology & Medical Technology
Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, June 14, 2006
Time: 9:30 am Eastern Time
Location: New York Palace Hotel, New York City
Audio Webcast: http://www.arraybiopharma.com
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat life threatening and debilitating diseases. Our proprietary
drug development pipeline is focused on the treatment of cancer and
inflammatory disease and includes clinical candidates that are designed to
regulate therapeutically important targets. In addition, leading
pharmaceutical and biotechnology companies collaborate with Array to
discover and develop drug candidates across a broad range of therapeutic
areas. For more information on Array, please go to http://www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
 back to top
Related links:
http://www.arraybiopharma.com/
CONTACT:
Tricia Haugeto of Array BioPharma Inc.,
+1-303-386-1193, thaugeto@arraybiopharma.com
|
